产品分类导航
甘精胰岛素  / Insulin Glargine
甘精胰岛素  / Insulin Glargine
甘精胰岛素  / Insulin Glargine

甘精胰岛素 / Insulin Glargine

更新时间:2025-06-18

价格:
CAS号: 160337-95-1
药典: 中国药典,美国药典,欧洲药典
级别: 注射级
立即询盘
收藏

产品详情
下载产品资料

产品名称: 甘精胰岛素 / Insulin Glargine
产品分类: 其他西药原料
CAS号: 160337-95-1
药典: 中国药典,美国药典,欧洲药典
级别: 注射级
产品关键词: 甘精胰岛素,Insulin Glargine
是否为生产商:
主要销售市场: 中国,北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
是否提供样品:

产品描述:

甘精胰岛素是一种长效人胰岛素类似物,A链和B链经修饰后在酸性条件下比普通胰岛素更稳定,作用时间可持续24小时。甘精胰岛素用于治疗糖尿病,可与胰岛素受体(IR)结合,以模仿内源性人胰岛素的活性,促进葡萄糖代谢。

本品由能高效表达甘精胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。

Glargine is a long-acting human insulin analog, with modified A and B chains that are more stable than regular insulin under acidic conditions and have a duration of action of up to 24 h. Insulin Glargine is commonly used in the treatment of diabetes and binds to the insulin receptor (IR) to mimic the activity of endogenous human insulin and promote glucose metabolism.

Virtu Pharmako utilizes E. coli strains to produce insulin glargine. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.

公司简介

恒敬生物根植于公司核心团队20多年的全球研发积累,创建国际领先的生物制药企业,自创成熟、高效、大规模、成本极具竞争力的生物医药产品,产品涵盖胰岛素类药物、GLP-1类药物以及更多的蛋白类、多肽类产品,位于嘉兴的先进工厂一期设计产能3吨原液和过亿支制剂,二期原液产能超10吨。Virtu Pharmako is a leading biopharmaceutical company with R&D, regulatory submission and CGMP manufacture engaged in four major business areas: Insulin drug portfolio, GLP-1 drug portfolio, biosynthetic technique corporations and varieties of protein/polypeptide bioproducts.With more than 20 years of global R&D study and commercial experiences, the company established the unique, innovative biotechnology platform which efficiently developed dozens of cost-competitive, environment friendly and commercial-scale biomedical products.Our state-of-art, world leading biopharmaceutical manufacture facility with building area 1 Million ft2 is built up in Jiaxing, Zhejiang, China, where located in near Metropolitan City, Shanghai. In Phase I, the production capacity includes 3 metric tonnes per year of API and over 120 million units per year of injectable. Production capacity of Phase II will surpasses 10 metric tonnes of API.
企业规模(人):
业务类型:
成立日期:
年销售额:
主营产品类别:

该公司其他产品

门冬胰岛素  / Insulin Aspart
门冬胰岛素 / Insulin Aspart
甘精胰岛素是一种长效人胰岛素类似物,A链和B链经修饰后在酸性条件下比普通胰岛素更稳定,作用时间可持续24小时。甘精胰岛素用于治疗糖尿病,可与胰岛素受体(IR)结合,以模仿内源性人胰岛素的活性,促进葡萄糖代谢。本品由能高效表达甘精胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。Glargine is a long-acting human insulin analog, with modified A and B chains that are more stable than regular insulin under acidic conditions and have a duration of action of up to 24 h. Insulin Glargine is commonly used in the treatment of diabetes and binds to the insulin receptor (IR) to mimic the activity of endogenous human insulin and promote glucose metabolism.Virtu Pharmako utilizes E. coli strains to produce insulin glargine. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.
德谷胰岛素  / Insulin Degludec
德谷胰岛素 / Insulin Degludec
甘精胰岛素是一种长效人胰岛素类似物,A链和B链经修饰后在酸性条件下比普通胰岛素更稳定,作用时间可持续24小时。甘精胰岛素用于治疗糖尿病,可与胰岛素受体(IR)结合,以模仿内源性人胰岛素的活性,促进葡萄糖代谢。本品由能高效表达甘精胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。Glargine is a long-acting human insulin analog, with modified A and B chains that are more stable than regular insulin under acidic conditions and have a duration of action of up to 24 h. Insulin Glargine is commonly used in the treatment of diabetes and binds to the insulin receptor (IR) to mimic the activity of endogenous human insulin and promote glucose metabolism.Virtu Pharmako utilizes E. coli strains to produce insulin glargine. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.
重组人胰岛素  / Recombinant Human Insulin
重组人胰岛素 / Recombinant Human Insulin
甘精胰岛素是一种长效人胰岛素类似物,A链和B链经修饰后在酸性条件下比普通胰岛素更稳定,作用时间可持续24小时。甘精胰岛素用于治疗糖尿病,可与胰岛素受体(IR)结合,以模仿内源性人胰岛素的活性,促进葡萄糖代谢。本品由能高效表达甘精胰岛素的大肠杆菌菌株经发酵而来,纯度高,内毒素含量极低,且不含任何动物源性病原体。Glargine is a long-acting human insulin analog, with modified A and B chains that are more stable than regular insulin under acidic conditions and have a duration of action of up to 24 h. Insulin Glargine is commonly used in the treatment of diabetes and binds to the insulin receptor (IR) to mimic the activity of endogenous human insulin and promote glucose metabolism.Virtu Pharmako utilizes E. coli strains to produce insulin glargine. It has extremely low endotoxin content with high purity, and does not contain any animal-derived pathogens.
恒敬合创生物医药(浙江)有限公司
注册资本
公司地址
浙江省嘉兴市中国浙江省嘉兴市南湖区大桥镇永叙路368号
联系人
查看联系方式
快速询盘
询盘主题
请输入询盘主题
询盘信息
请输入询盘信息
快速发送询盘
2006-2026 上海博华国际展览有限公司版权所有(保留一切权利) 沪ICP备05034851号-57